Lack of D1 receptor leads to slowness of movements in Parkinson's disease

Parkinson's disease
Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson's disease. Credit: Wikipedia

Dopamine deficiency in the basal ganglia (a set of subcortical structures) causes severe motor dysfunctions, such as slowness of movements (bradykinesia), as observed in Parkinson's disease. Dopamine binds D1 and D2 receptors that are expressed in the nerve cells of the striatum (a structure of the basal ganglia), and exerts different effects on the nerve cells. However, how dopamine controls through these receptors the information flow in the basal ganglia and voluntary movements is still not clear.

Assistant Professor Satomi Chiken and Professor Atsushi Nambu from National Institute for Physiological Sciences, Dr. Asako Sato from Kitasato University, Professor Toshikuni Sasaoka from Niigata University, and their research team members have revealed that lack of dopamine transmission through D1 disturbs through the "direct pathway" in the basal ganglia, and ends up in difficulty in initiating voluntary movements. This study was supported by JSPS KAKENHI and CREST, and published online in the Oxford journal Cerebral Cortex on October 7, 2015.

The research team successfully developed a novel transgenic mouse model in which dopamine D1 receptors can be reversibly reduced by a pharmacological agent "doxycycline", and found that the mice showed decreased movements when D1 receptors were reduced. The team used electrophysiological techniques in awake mice and examined the electrical activity of the nerve cells in the entopeduncular nucleus (EPN, the homologous structure to the internal segment of the globus pallidus in humans) that is the output station of the . Normally, the electrical stimulation of the motor cortex, which resembles the electrical activity during voluntary movements, causes triphasic response consisting of early excitation, inhibition and late excitation in the nerve cells of the EPN, and the "inhibition" is mediated by the "direct pathway" and acts to initiate movements. When D1 receptors were reduced in the transgenic mice by "doxycycline", the triphasic response was changed, and the "inhibition" was largely decreased. These results suggest that dopamine transmission mediated by D1 receptors is essential for information flow through the "direct pathway" to appropriately initiate movements. The research team also revealed that spontaneous activity of in the ENP did not change when D1 receptors were reduced, which denies the prevalent view that lack of D1 receptor-mediated dopamine transmission increases spontaneous nerve cell activity in the EPN. The results suggest that transient activity changes through the "direct pathway", not spontaneous activity changes, in the EPN are responsible for slowness of movements in Parkinson's disease.

"We have shown that lack of dopamine transmission via D1 receptors disrupts information flow through the 'direct pathway' and results in slowness of movements in Parkinson's disease. This finding provides us important clues to develop new therapies to the disease, such as on-demand activation of D1 receptors to facilitate the information flow through the 'direct pathway'", Professor Nambu said.

Explore further

Faced with decisions, humans may be wired to say, 'no'

Journal information: Cerebral Cortex

Provided by National Institutes of Natural Sciences
Citation: Lack of D1 receptor leads to slowness of movements in Parkinson's disease (2015, October 6) retrieved 27 January 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors